BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22926563)

  • 1. Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane.
    Wenzel M; Kohl B; Münch D; Raatschen N; Albada HB; Hamoen L; Metzler-Nolte N; Sahl HG; Bandow JE
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5749-57. PubMed ID: 22926563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of the σ(W) , σ(M) and σ(X) regulons to the lantibiotic resistome of Bacillus subtilis.
    Kingston AW; Liao X; Helmann JD
    Mol Microbiol; 2013 Nov; 90(3):502-18. PubMed ID: 23980836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
    Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
    Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.
    Hasper HE; Kramer NE; Smith JL; Hillman JD; Zachariah C; Kuipers OP; de Kruijff B; Breukink E
    Science; 2006 Sep; 313(5793):1636-7. PubMed ID: 16973881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
    Bonelli RR; Schneider T; Sahl HG; Wiedemann I
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1449-57. PubMed ID: 16569864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell envelope stress response in cell wall-deficient L-forms of Bacillus subtilis.
    Wolf D; Domínguez-Cuevas P; Daniel RA; Mascher T
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5907-15. PubMed ID: 22964256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo cluster formation of nisin and lipid II is correlated with membrane depolarization.
    Tol MB; Morales Angeles D; Scheffers DJ
    Antimicrob Agents Chemother; 2015; 59(6):3683-6. PubMed ID: 25870072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin.
    Gut IM; Blanke SR; van der Donk WA
    ACS Chem Biol; 2011 Jul; 6(7):744-52. PubMed ID: 21517116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microtiter plate bioassay to monitor the interference of antibiotics with the lipid II cycle essential for peptidoglycan biosynthesis.
    Burkard M; Stein T
    J Microbiol Methods; 2008 Sep; 75(1):70-4. PubMed ID: 18558445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial mechanism of lantibiotics.
    Islam MR; Nagao J; Zendo T; Sonomoto K
    Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
    Wiedemann I; Böttiger T; Bonelli RR; Schneider T; Sahl HG; Martínez B
    Appl Environ Microbiol; 2006 Apr; 72(4):2809-14. PubMed ID: 16597986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane lipids determine the antibiotic activity of the lantibiotic gallidermin.
    Christ K; Al-Kaddah S; Wiedemann I; Rattay B; Sahl HG; Bendas G
    J Membr Biol; 2008; 226(1-3):9-16. PubMed ID: 19009315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
    Wiedemann I; Böttiger T; Bonelli RR; Wiese A; Hagge SO; Gutsmann T; Seydel U; Deegan L; Hill C; Ross P; Sahl HG
    Mol Microbiol; 2006 Jul; 61(2):285-96. PubMed ID: 16771847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid II as a target for antibiotics.
    Breukink E; de Kruijff B
    Nat Rev Drug Discov; 2006 Apr; 5(4):321-32. PubMed ID: 16531990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of subtilin and nisin biosyntheses: biosynthesis of lantibiotics.
    Entian KD; de Vos WM
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):109-17. PubMed ID: 8775971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5.
    Paiva AD; Breukink E; Mantovani HC
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5284-93. PubMed ID: 21876041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The localization of key Bacillus subtilis penicillin binding proteins during cell growth is determined by substrate availability.
    Lages MC; Beilharz K; Morales Angeles D; Veening JW; Scheffers DJ
    Environ Microbiol; 2013 Dec; 15(12):3272-81. PubMed ID: 23895585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study.
    Wiedemann I; Benz R; Sahl HG
    J Bacteriol; 2004 May; 186(10):3259-61. PubMed ID: 15126490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif.
    Böttiger T; Schneider T; Martínez B; Sahl HG; Wiedemann I
    Appl Environ Microbiol; 2009 Jul; 75(13):4427-34. PubMed ID: 19429551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.
    Wiedemann I; Breukink E; van Kraaij C; Kuipers OP; Bierbaum G; de Kruijff B; Sahl HG
    J Biol Chem; 2001 Jan; 276(3):1772-9. PubMed ID: 11038353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.